Intuitive Surgical Inc. ($ISRG) Stock Forecast: Up 5.0% Today

What is Intuitive Surgical Inc.?

Intuitive Surgical, Inc. (ISRG) is a leading provider of medical equipment, particularly recognized for its innovative robotic-assisted surgical systems. The company's advanced technologies have garnered attention in the healthcare industry.

Why is Intuitive Surgical Inc. going up?

ISRG stock is up 5.0% on Jan 6, 2026 20:20

• Noteworthy insider selling by Greenleaf Trust and Hennion & Walsh Asset Management Inc. did not deter overall market optimism towards ISRG today.
• Discussions around the utilization of Artificial Intelligence (AI) in the medical sector, including within companies like ISRG, likely influenced investor sentiment positively, reflecting interest in the company's growth prospects.
• ISRG's strong earnings report, surpassing revenue and EPS projections, is seen as a key factor reinforcing investor trust in the company's future performance.
• Variations in institutional investors' behavior, with some increasing stakes and others decreasing positions in ISRG, suggest diverse views on the company's long-term outlook. Nevertheless, the prevailing market sentiment remained favorable, supporting the bullish trend in ISRG.

ISRG Price Chart

ISRG Technical Analysis

ISRG News

Micron and Lam Research among market cap stock movers on Tuesday

Tuesday's market saw significant movement in various stocks. Micron Technology (MU) and Lam Research (LRCX) rallied, with Lam Research receiving a "Buy" rating from Aletheia Capital, while Applovin (APP) and Tesla Motors (TSLA) experienced declines. The article highlights top movers across mega-cap, large-cap, mid-cap, and small-cap categories, detailing percentage changes and specific news events driving these shifts.

https://www.investing.com/news/stock-market-news/micron-and-lam-research-among-market-cap-stock-movers-on-tuesday-93CH-4432953

Intuitive Surgical, Inc. $ISRG Shares Sold by Greenleaf Trust

Greenleaf Trust significantly reduced its stake in Intuitive Surgical (ISRG) by 43.4% in Q3, selling 8,798 shares. This comes despite major institutional investors like Vanguard and Norges Bank increasing their positions, and Intuitive Surgical exceeding revenue and EPS expectations. Insider selling also saw 114,007 shares sold last quarter, totaling over $63 million.

https://www.marketbeat.com/instant-alerts/filing-intuitive-surgical-inc-isrg-shares-sold-by-greenleaf-trust-2026-01-06/

Hennion & Walsh Asset Management Inc. Cuts Stock Position in Intuitive Surgical, Inc. $ISRG

Hennion & Walsh Asset Management Inc. significantly reduced its stake in Intuitive Surgical, Inc. (ISRG) by 13.9% in the third quarter of 2025, selling 2,207 shares and holding 13,638 shares valued at $6.10 million. Concurrently, company insiders have sold 114,007 shares totaling $63.53 million in the past three months, notably CEO Gary S. Guthart decreasing his ownership by nearly 90%. Despite these sales, analysts generally maintain a "Moderate Buy" rating for ISRG with an average price target of $612.75, showing continued optimism for the medical equipment provider.

https://www.marketbeat.com/instant-alerts/filing-hennion-walsh-asset-management-inc-cuts-stock-position-in-intuitive-surgical-inc-isrg-2026-01-06/

The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson

This Zacks Analyst Blog highlights five medical sector stocks—Eli Lilly (LLY), Medtronic (MDT), Intuitive Surgical (ISRG), Regeneron Pharmaceuticals (REGN), and Johnson & Johnson (JNJ)—that are leveraging Artificial Intelligence (AI) to drive growth and innovation. The article details how each company uses AI to enhance diagnostics, drug discovery, surgical systems, and operational efficiency, positioning them for strong performance in 2026. These companies are transforming the medical landscape by integrating AI into their core operations, leading to improved patient outcomes and significant market potential.

https://www.theglobeandmail.com/investing/markets/stocks/JNJ/pressreleases/36900127/the-zacks-analyst-blog-eli-lilly-medtronic-intuitive-surgical-regeneron-pharmaceuticals-and-johnson-johnson/

The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson

This Zacks Analyst Blog highlights five medical-sector stocks, Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals, and Johnson & Johnson, that are leveraging Artificial Intelligence (AI) to drive growth and innovation. The article discusses how AI is transforming diagnostics, treatment, and operational efficiency within the healthcare industry and provides financial insights and strategic applications of AI for each company. These companies are identified as potential high-growth providers due to their extensive use of AI.

https://www.theglobeandmail.com/investing/markets/stocks/LLY/pressreleases/36900127/the-zacks-analyst-blog-eli-lilly-medtronic-intuitive-surgical-regeneron-pharmaceuticals-and-johnson-johnson/

Trending Today

FuelCell Energy ($FCEL) Stock Forecast: Up 5.4% Today

American Eagle Outfitters Inc. ($AEO) Stock Forecast: Up 5.1% Today

Monero ($XMR) Crypto Forecast: Up 14.6% Today

Marathon Digital Holdings Inc. ($MARA) Stock Forecast: Up 5.4% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Up 5.2% Today

Cronos Group Inc. ($CRON) Stock Forecast: Up 2.6% Today

Oracle Corporation ($ORCL) Stock Forecast: Up 3.4% Today

fuboTV Inc. ($FUBO) Stock Forecast: Up 3.7% Today

Unity Software ($U) Stock Forecast: Up 5.0% Today

Tilray Inc. ($TLRY) Stock Forecast: Up 4.9% Today

Intuitive Surgical Inc. Price History

23.03.2025 - ISRG Stock was up 7.0%

• Intuitive Surgical reported impressive Q1 earnings and revenue, beating analyst estimates, which likely contributed to the bullish market movement.
• Despite concerns about profit margin impact from tariffs, the company's solid financial performance and optimistic outlook buoyed investor confidence.
• Analysts remain bullish on ISRG, providing support for the stock even amidst technical bearish trends.
• The anticipation of strong performance in the Instruments & Accessories segment further fueled optimism among investors, driving the stock's upward trajectory.

09.05.2025 - ISRG Stock was up 2.5%

• ISRG's shares have been on a recovery path, gaining 12.7% quarter-to-date after a significant decline from its all-time high. Investors are now eyeing the stock for a potential buying opportunity.
• The company's latest innovation, the da Vinci 5 surgical system, is garnering attention for its precision, power, and potential, with strong placements in Q1 driving adoption rates.
• ISRG outpaced the stock market gains, closing the day with a 1.11% increase, showcasing resilience and investor confidence in the company's future prospects.
• The options market sentiment towards ISRG is notably bullish, indicating a positive outlook from deep-pocketed investors. This optimism could be contributing to the stock's upward momentum as market players take note of this significant move.

07.03.2025 - ISRG Stock was up 7.9%

• The upward movement in ISRG's stock price may be linked to positive options market sentiment from influential investors, indicating confidence in the company's potential growth.
• Speculation about Intuitive Surgical surpassing earning projections in the upcoming report might have also influenced the positive trend, showcasing investor trust in the company's financial performance.
• Investor optimism regarding ISRG's future outlook and its consistent strong results is evident in the market's response, propelling the stock price upwards.

09.03.2025 - ISRG Stock was down 5.0%

• The decline in ISRG stock today may be linked to investors cashing in on profits following a recent upward movement.
• Optimistic activity in the options market could suggest a favorable future outlook for ISRG, notwithstanding the current short-term stock decline.
• Expectations of a positive earnings performance in the upcoming quarterly results might be fueling the overall positive sentiment, even with today's slight stock drop.

10.11.2025 - ISRG Stock was down 2.8%

• An institutional investor increased its stake in ISRG by 1.2% in Q2, despite recent insider selling by executives, following the company's strong Q3 earnings.
• Another institutional investor, Daiwa Securities Group Inc., sold 6,055 shares of ISRG, reducing its holdings, while other institutional investors also adjusted their positions in the company.
• The market movement could be attributed to profit-taking by institutional investors after a period of significant growth, despite positive earnings and analyst consensus ratings.
• The bearish trend might also be influenced by overall market conditions and investor sentiment towards the healthcare sector, as highlighted by the positive performance of other surgical equipment companies in Q3.

06.00.2026 - ISRG Stock was up 3.7%

• Despite significant insider selling and reduced stakes by asset management firms, major institutional investors increasing their positions in ISRG have likely instilled confidence in the market.
• The utilization of AI in driving growth and innovation within the medical sector has positioned companies like Intuitive Surgical for strong performance, attracting investors and contributing to the bullish movement.
• While the stock may be trading at a premium valuation with a high P/E ratio, the perceived undervaluation and potential for future growth due to product innovation and AI integration have likely fueled investor optimism, leading to the bullish market movement.

06.00.2026 - ISRG Stock was up 5.0%

• Noteworthy insider selling by Greenleaf Trust and Hennion & Walsh Asset Management Inc. did not deter overall market optimism towards ISRG today.
• Discussions around the utilization of Artificial Intelligence (AI) in the medical sector, including within companies like ISRG, likely influenced investor sentiment positively, reflecting interest in the company's growth prospects.
• ISRG's strong earnings report, surpassing revenue and EPS projections, is seen as a key factor reinforcing investor trust in the company's future performance.
• Variations in institutional investors' behavior, with some increasing stakes and others decreasing positions in ISRG, suggest diverse views on the company's long-term outlook. Nevertheless, the prevailing market sentiment remained favorable, supporting the bullish trend in ISRG.

02.00.2026 - ISRG Stock was down 1.2%

• The downturn in ISRG stock today may be linked to investors seizing profits following a recent rise in the stock price.
• Despite notable developments like a robust Q3 performance and increased interest from institutional investors, market sentiment could be swayed by overall uncertainty and volatility in the healthcare domain.
• The forthcoming Q4 earnings call set for January 22 might influence the stock's trajectory, as investors await insights on future growth prospects.
• The market's perception of ISRG could also be influenced by broader economic conditions and industry trends impacting healthcare and technology sectors.

22.09.2025 - ISRG Stock was up 16.5%

• ISRG exceeded Q3 earnings and revenue expectations, demonstrating robust financial performance.
• The introduction of the new da Vinci 5 system is stimulating hospital upgrades and premium pricing, potentially influencing the strong performance in Q3.
• Investors responded favorably to ISRG's solid Q3 results, resulting in a notable increase in the stock price.
• The company's consistent track record of impressive earnings and positive future prospects are likely driving the current bullish trend in ISRG's stock.

22.09.2025 - ISRG Stock was up 13.4%

• Third-quarter results revealed that Intuitive Surgical achieved $2.51 billion in revenue, a 23% increase from the previous year, surpassing predictions. The surge in da Vinci placements and global procedure growth fueled this remarkable performance.
• Despite a slight gross margin dip, the company's adjusted earnings of $2.40 per share exceeded forecasts, propelling ISRG stock by 17%.
• Investor optimism was evident as the market responded favorably to the earnings and revenue beat, showcasing confidence in Intuitive Surgical's financial prowess and industry prominence.
• With a track record of surpassing earnings estimates and a bright outlook, Intuitive Surgical is positioned to potentially surpass expectations in the future, contributing to the bullish trend in its stock value.

01.09.2025 - ISRG Stock was down 2.1%

• The bearish movement in ISRG stock may be linked to profit-taking by investors following a recent positive trend.
• Concerns over the national security review affecting the medical supply chain may have contributed to uncertainty in the healthcare sector, prompting a sell-off in ISRG shares.
• There might be worries among investors about potential disruptions in the supply chain of medical devices, including robotic surgery systems, which could impact ISRG's operations and revenue.
• The market's response to the national security review may have sparked a broader sell-off in healthcare stocks, including ISRG, as investors reevaluate the risks associated with the sector.

23.06.2025 - ISRG Stock was down 2.8%

• Despite exceeding Q2 earnings and revenue estimates, ISRG's stock took a bearish turn.
• Concerns rose among investors due to a decrease in gross margin outlook impacted by tariffs, overshadowing the positive earnings results.
• The FDA's approval for ISRG's Vessel Sealer Curved, adding to the da Vinci system's capabilities, may have been overshadowed by the margin outlook news.
• Comparisons with rival Stryker in the robotic surgery sector potentially affected investor sentiment, contributing to the bearish trend in ISRG's stock.